Pancreatitis risk with liraglutide requires attention
Genetic variations in GLP-1 receptor (GLP1R), GIP receptor (GIPR), and appetite-regulation genes (FTO, MC4R) can predispose individuals to greater weight gain and reduced satiety signals
It is not a form of insulin replacement therapy
GLP-1 receptor agonists (GLP-1 RAs) are mainly prescribed for people with type 2 diabetes and are not commonly used as a standard treatment for type 1 diabetes, since people with type 1 diabetes do not produce insulin and rely on insulin therapy as their primary treatment
Pharmacist-facilitated enrollment in medication assistance programs in a private ambulatory care clinic
Additionally, the effects of GLP-1RAs on cognitive processes are currently being explored, broadening our understanding of their therapeutic mechanism in controlling metabolism